IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - MarketWatch
1. IGM Biosciences is cutting 73% of its workforce, impacting 144 employees. 2. The company halted its autoimmunity-drug pipeline development, signaling strategic shifts. 3. IGMS had 198 employees in September, now significantly downsizing. 4. This move may influence investor confidence and future stock performance.